Advertisement

Topics

Expert Highlights Potential of Erdafitinib in Urothelial Carcinoma

12:50 EDT 10 Aug 2018 | OncLive

Arlene O. Siefker-Radtke, MD, discusses the promise of erdafitinib in patients with urothelial carcinoma.

Original Article: Expert Highlights Potential of Erdafitinib in Urothelial Carcinoma

NEXT ARTICLE

More From BioPortfolio on "Expert Highlights Potential of Erdafitinib in Urothelial Carcinoma"

Advertisement
Quick Search
Advertisement
Advertisement